Molecular and phenotypic characterization of 5-FU resistant colorectal cancer cells: toward enrichment of cancer stem cells

被引:0
作者
Babajnai, Amirhesam [1 ]
Rahmani, Saeed [1 ]
Asadi, Mohammad Jamal [2 ]
Gheytanchi, Elmira [1 ]
Adibhesami, Glavizh [1 ]
Vakhshiteh, Faezeh [1 ]
Madjd, Zahra [1 ,3 ]
机构
[1] Iran Univ Med Sci, Oncopathol Res Ctr, Tehran, Iran
[2] Sharif Univ Technol, Dept Comp Engn, Tehran, Iran
[3] Iran Univ Med Sci, Fac Adv Technol Med, Dept Mol Med, Tehran, Iran
关键词
Cancer stem cell; Colorectal cancer; 5-FU; EMT; ABC; Drug resistance; MARKERS; 5-FLUOROURACIL; CORRELATE; PARADIGM; ROLES; CD133; LINES; CD44;
D O I
10.1186/s12935-025-03758-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer stem cells (CSCs) as a subgroup of cells within a tumor capable of self-renewal, thereby driving tumor initiation and spread. Addressing treatment failures in cancer, linked to CSCs and their resistance mechanisms, requires effective preclinical models for testing targeted therapies. Caco2- and HT-29-resistant cells were generated by repeated treatment of cells with growing concentrations of 5-fluorouracil (5-FU) anticancer drug for an extended time. The sensitivity of 5-FU-resistant cells was evaluated by cytotoxicity assay. Stemness, epithelial-mesenchymal transition (EMT), migration and drug resistance characteristics were assessed through gene expression investigation by real-time PCR. The expression of CD44, CD133, and CD66 were evaluated by flow cytometry. To end, the bioinformatic analysis estimated the molecular function and biological pathways considering the differential expression of selected genes and proteins. 5-FU-exposed cells displayed increased resistance to 5-FU. The gene expression analysis showed an upregulation of stemness genes (KLF4, SOX2, OCT4, C-MYC), enhanced scavenging system, and elevated expression of CSC surface markers (CD44 and CD133) compared to parental cells. Additionally, pro-EMT genes (TWIST1, SNAIL1, ZEB1, Vimentin, and N-cadherin) were significantly upregulated compared to parental cells, with the downregulation of E-cadherin as an EMT suppressor gene reflected in increased migration capacity. Moreover, increased expression of ABC transporter genes (ABCB1, ABCC1) was observed, correlating with enhanced drug resistance. The bioinformatic analysis highlighted pathways related to microRNAs in cancer, cells pluripotency, and proteoglycans. Methods of drug exposure take priority over spheroid formation, particularly due to their enhanced efficacy in stemness, EMT, and surface markers. This positions them as a promising protocol for establishing experimental models of CSCs.
引用
收藏
页数:17
相关论文
共 50 条
[41]   Role and molecular mechanism of stem cells in colorectal cancer initiation [J].
Wang, Meng-Yan ;
Qiu, Yu-Han ;
Cai, Mei-Lian ;
Zhang, Cong-Hui ;
Wang, Xiao-Wei ;
Liu, Hong ;
Yi-Chen ;
Zhao, Wu-Li ;
Liu, Jing-Bo ;
Shao, Rong-Guang .
JOURNAL OF DRUG TARGETING, 2020, 28 (01) :1-10
[42]   Suramin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in metastatic colorectal cancer patients resistant to 5-FU+LV-based chemotherapy [J].
Falcone, A ;
Pfanner, E ;
Brunetti, I ;
Allegrini, G ;
Lencioni, M ;
Galli, C ;
Masi, G ;
Danesi, D ;
Antonuzzo, A ;
Del Tacca, M ;
Conte, PF .
TUMORI, 1998, 84 (06) :666-668
[43]   DKK4 enhances resistance to chemotherapeutics 5-Fu and YN968D1 in colorectal cancer cells [J].
He, Shengli ;
Shen, Jie ;
Hu, Nanhua ;
Xu, Xuanfu ;
Li, Jin .
ONCOLOGY LETTERS, 2017, 13 (02) :587-592
[44]   Recurrence and 5-FU sensitivity of stage III/Dukes' C colorectal cancer with occult neoplastic cells in lymph node sinuses [J].
Mukai, M ;
Sato, S ;
Ninomiya, H ;
Wakui, K ;
Komatsu, N ;
Tsuchiya, K ;
Nakasaki, H ;
Makuuchi, H .
ONCOLOGY REPORTS, 2005, 14 (05) :1165-1169
[45]   Combinational inhibition of EGFR and YAP reverses 5-Fu resistance in colorectal cancer [J].
Huang, Changhao ;
Chen, Zihua ;
Yang, Chen ;
Chen, Lu ;
Lai, Chen ;
Zhang, Yingying ;
Yuan, Weijie ;
Jeong, Ji-Hak .
JOURNAL OF CANCER, 2020, 11 (18) :5432-5439
[46]   miR-206 regulates 5-FU resistance by targeting Bcl-2 in colon cancer cells [J].
Meng, Xiaomin ;
Fu, Rao .
ONCOTARGETS AND THERAPY, 2018, 11 :1757-1765
[47]   PAR2 Inhibition Enhanced the Sensitivity of Colorectal Cancer Cells to 5-FU and Reduced EMT Signaling [J].
Quan, Qiuying ;
Zhong, Fengyun ;
Wang, Xinwei ;
Chen, Kai ;
Guo, Lingchuan .
ONCOLOGY RESEARCH, 2019, 27 (07) :779-788
[48]   Differences and Similarities between Colorectal Cancer Cells and Colorectal Cancer Stem Cells: Molecular Insights and Implications [J].
Erisik, Derya ;
Ozdil, Berrin ;
Acikgoz, Eda ;
Asker Abdikan, Cemile Sinem ;
Yesin, Taha Kadir ;
Aktug, Huseyin .
ACS OMEGA, 2023, 8 (33) :30145-30157
[49]   Exosomal transfer of p-STAT3 promotes acquired 5-FU resistance in colorectal cancer cells [J].
Qian Zhang ;
Rui-Xian Liu ;
Ka-Wo Chan ;
Jiancong Hu ;
Jingdan Zhang ;
Lili Wei ;
Huiliu Tan ;
Xiangling Yang ;
Huanliang Liu .
Journal of Experimental & Clinical Cancer Research, 38
[50]   Arsenic Trioxide Suppresses Thymidylate Synthase in 5-FU-resistant Colorectal Cancer Cell Line HT29 In Vitro Re-sensitizing Cells to 5-FU [J].
Subbarayan, Pochi Ramalingam ;
Lee, Kelvin ;
Ardalan, Bach .
ANTICANCER RESEARCH, 2010, 30 (04) :1157-1162